Response to: 'Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1' by Michot et al and 'Checkpoint inhibitor-associated immune arthritis' by Arnaud et al

Ann Rheum Dis. 2019 Jul;78(7):e69. doi: 10.1136/annrheumdis-2018-213691. Epub 2018 Jun 22.

Authors

Marie Kostine¹, Christophe Richez¹, Thierry Schaeverbeke¹; FHU- ACRONIM

Affiliation

¹ Department of Rheumatology, Centre Hospitalier Universitaire, Bordeaux, France.

PMID: 29934372
DOI: 10.1136/annrheumdis-2018-213691

No abstract available

Keywords: T cells; autoimmune diseases; multidisciplinary team-care; systemic lupus erythematosus; treatment.

Publication types

Letter
Comment

MeSH terms

Arthritis*
Humans
Immunotherapy
Lupus Erythematosus, Systemic*
Neoplasms*
Prospective Studies